Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Inflammatory biomarkers and exacerbations in chronic obstructive pulmonary disease

Research output: Contribution to journalJournal articleResearchpeer-review

Harvard

APA

CBE

MLA

Vancouver

Author

Bibtex

@article{648f6a0f240c41f3bc4f516bdd9c50b9,
title = "Inflammatory biomarkers and exacerbations in chronic obstructive pulmonary disease",
abstract = "Exacerbations of respiratory symptoms in chronic obstructive pulmonary disease (COPD) have profound and long-lasting adverse effects on patients.",
keywords = "Adrenal Cortex Hormones, Aged, Anti-Bacterial Agents, Biological Markers, C-Reactive Protein, Disease Progression, Female, Fibrinogen, Forced Expiratory Volume, Humans, Inflammation, Leukocyte Count, Male, Middle Aged, Odds Ratio, Patient Admission, Prospective Studies, Pulmonary Disease, Chronic Obstructive, Risk, Risk Assessment, Severity of Illness Index, Vital Capacity",
author = "Mette Thomsen and Ingebrigtsen, {Truls Sylvan} and Marott, {Jacob Louis} and Morten Dahl and Peter Lange and J{\o}rgen Vestbo and Nordestgaard, {B{\o}rge G}",
year = "2013",
month = "6",
day = "12",
doi = "10.1001/jama.2013.5732",
language = "English",
volume = "309",
pages = "2353--61",
journal = "JAMA - Journal of the American Medical Association",
issn = "0002-9955",
publisher = "American Medical Association",
number = "22",

}

RIS

TY - JOUR

T1 - Inflammatory biomarkers and exacerbations in chronic obstructive pulmonary disease

AU - Thomsen, Mette

AU - Ingebrigtsen, Truls Sylvan

AU - Marott, Jacob Louis

AU - Dahl, Morten

AU - Lange, Peter

AU - Vestbo, Jørgen

AU - Nordestgaard, Børge G

PY - 2013/6/12

Y1 - 2013/6/12

N2 - Exacerbations of respiratory symptoms in chronic obstructive pulmonary disease (COPD) have profound and long-lasting adverse effects on patients.

AB - Exacerbations of respiratory symptoms in chronic obstructive pulmonary disease (COPD) have profound and long-lasting adverse effects on patients.

KW - Adrenal Cortex Hormones

KW - Aged

KW - Anti-Bacterial Agents

KW - Biological Markers

KW - C-Reactive Protein

KW - Disease Progression

KW - Female

KW - Fibrinogen

KW - Forced Expiratory Volume

KW - Humans

KW - Inflammation

KW - Leukocyte Count

KW - Male

KW - Middle Aged

KW - Odds Ratio

KW - Patient Admission

KW - Prospective Studies

KW - Pulmonary Disease, Chronic Obstructive

KW - Risk

KW - Risk Assessment

KW - Severity of Illness Index

KW - Vital Capacity

U2 - 10.1001/jama.2013.5732

DO - 10.1001/jama.2013.5732

M3 - Journal article

VL - 309

SP - 2353

EP - 2361

JO - JAMA - Journal of the American Medical Association

JF - JAMA - Journal of the American Medical Association

SN - 0002-9955

IS - 22

ER -

ID: 41900883